# Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve

> **NCT02953041** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 31 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Glycopyrronium
- **DRUG:** Indacaterol

## Key facts

- **NCT ID:** NCT02953041
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953041, "Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02953041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*